Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 79
Filter
4.
Indian J Ophthalmol ; 71(8): 3069-3079, 2023 08.
Article in English | MEDLINE | ID: mdl-37530283

ABSTRACT

Purpose: To explore the vitreous humor proteome from type 2 diabetes subjects with proliferative diabetic retinopathy (PDR) in the Indian population. Methods: We performed mass spectrometry-based label-free quantitative analysis of vitreous proteome of PDR (n = 13) and idiopathic macular hole (IMH; control) subjects (n = 14). Nine samples of PDR and 10 samples of IMH were pooled as case and control, respectively, and compared. Four samples each of PDR and IMH were analyzed individually without pooling to validate the results of the pooled analysis. Comparative quantification was performed using Scaffold software which calculated the fold changes of differential expression. Bioinformatics analysis was performed using DAVID and STRING software. Results: We identified 469 proteins in PDR and 517 proteins in IMH vitreous, with an overlap of 172 proteins. Also, 297 unique proteins were identified in PDR and 345 in IMH. In PDR vitreous, 37 proteins were upregulated (P < 0.05) and 19 proteins were downregulated compared to IMH. Protein distribution analysis clearly demonstrated a separation of protein expression in PDR and IMH. Significantly upregulated proteins included fibrinogen gamma chain, fibrinogen beta chain, and carbonic anhydrase 1 and downregulated proteins included alpha-1-antitrypsin, retinol-binding protein 3, neuroserpin, cystatin C, carboxypeptidase E and cathepsin-D. Conclusion: Diabetic retinopathy pathogenesis involves proteins which belong to inflammation, visual transduction, and extracellular matrix pathways. Validation-based experiments using enzyme-linked immunosorbent assay (ELISA) or western blotting are needed to establish cause and effect relationships of these proteins to the disease state, to develop them as biomarkers or drug molecules.


Subject(s)
Diabetes Mellitus, Type 2 , Diabetic Retinopathy , Humans , Diabetic Retinopathy/diagnosis , Diabetes Mellitus, Type 2/complications , Diabetes Mellitus, Type 2/metabolism , Proteome/analysis , Proteome/metabolism , Proteomics/methods , Vision, Ocular , Inflammation , Extracellular Matrix/chemistry , Extracellular Matrix/metabolism , Fibrinogen , Enzyme-Linked Immunosorbent Assay
6.
Indian J Ophthalmol ; 71(3): 933-934, 2023 03.
Article in English | MEDLINE | ID: mdl-36872712

Subject(s)
Retina , Humans
7.
Indian J Ophthalmol ; 71(2): 400-401, 2023 02.
Article in English | MEDLINE | ID: mdl-36727326
10.
Indian J Ophthalmol ; 71(2): 647-648, 2023 02.
Article in English | MEDLINE | ID: mdl-36727379
12.
Ocul Immunol Inflamm ; 31(4): 838-842, 2023 May.
Article in English | MEDLINE | ID: mdl-35404737

ABSTRACT

AIM: To report the management of a neonate who presented with simultaneous bilateral central retinal vein occlusion (CRVO) secondary to septicemia. DESIGN: Case Report. RESULTS: A full-term infant was treated for neonatal sepsis with thrombocytopenia. He presented with poorly dilating pupil, disc edema, dilated retinal veins, perivascular exudation, retinal hemorrhages in all four quadrants radiating from the optic nerve to the ora serrata (no Roth spots), with cystoid macular edema (CME) in both the eyes. His TORCH serology was negative and peripheral blood film was normal. He was diagnosed as presumptive bilateral inflammatory CRVO with CME secondary to septicemia. He received bilateral intravitreal bevacizumab injections. After the injection, his pupils dilated completely while retinal hemorrhages and CME reduced. CONCLUSION: CRVO may present as a rare complication in neonates suffering from septicemia. Apart from the systemic treatment, aggressive ocular treatment is needed to salvage the eyes with severe ischemia.


Subject(s)
Macular Edema , Retinal Vein Occlusion , Sepsis , Male , Infant, Newborn , Humans , Retinal Vein Occlusion/diagnosis , Retinal Vein Occlusion/drug therapy , Retinal Vein Occlusion/complications , Angiogenesis Inhibitors/therapeutic use , Retinal Hemorrhage/drug therapy , Bevacizumab/therapeutic use , Macular Edema/drug therapy , Intravitreal Injections , Tomography, Optical Coherence , Sepsis/complications , Sepsis/drug therapy
13.
Eur J Ophthalmol ; 33(1): 483-488, 2023 Jan.
Article in English | MEDLINE | ID: mdl-35581714

ABSTRACT

AIM: To report the outcomes of the "inverse drainage Nd:YAG laser membranotomy" technique for the management of pre-macular hemorrhage (PMH), which has its inferior margin near the fovea. METHODS: This retrospective study included eyes with PMH, with its inferior margin located within 0.5 disc-diameter (DD) of the fovea. Laser membranotomy was performed near the superior margin of PMH followed by intravitreal injection of 0.3 mL undiluted sulphur hexafluoride (SF6) gas. The patients were advised to maintain a prone position for three days. RESULTS: Twenty patients (20 eyes) with a mean age of 46.1 ± 18.6 years were included in the study. The mean duration of symptoms was 6.9 ± 7.0 days. The mean size of PMH was 4.1 ± 1.2DD. The causes of PMH were Valsalva retinopathy (n = 11) and retinal artery macroaneurysm (RAM, n = 9). The mean maximum height of the blood collection, measured by optical coherence tomography (OCT), within 1 disc-diameter from the inferior and superior borders of the PMH was 738.9 ± 232.9µm and 1240.6 ± 338.1µm respectively (p = 0.001). The mean best-corrected visual acuity (BCVA) improved from logMAR 1.32 ± 0.44 (Snellen equivalent, 20/418) to logMAR 0.11 ± 0.20 (Snellen equivalent, 20/26) (p = 0.001). Vitrectomy was not required in any case. Persistent pre-macular cavity, macular hole, epiretinal membrane (ERM), intra-ocular pressure spike, or rhegmatogenous retinal detachment (RRD) was not noted in any patient. CONCLUSION: This technique can be safely used to treat eyes with PMH having its inferior margin near the fovea.


Subject(s)
Epiretinal Membrane , Retinal Detachment , Humans , Adult , Middle Aged , Retrospective Studies , Retinal Hemorrhage/diagnosis , Retinal Hemorrhage/etiology , Retinal Hemorrhage/surgery , Retinal Detachment/surgery , Epiretinal Membrane/surgery , Tomography, Optical Coherence , Drainage
15.
BMJ Case Rep ; 15(11)2022 Nov 16.
Article in English | MEDLINE | ID: mdl-36384883

ABSTRACT

Phakomatoses are a group of congenital disorders characterised by hamartomatous lesions of the skin as well as the central and peripheral nervous systems. The presence of naevus flammeus or port-wine stain is a characteristic feature of many such disorders including Sturge-Weber syndrome (SWS), Klippel-Trenaunay syndrome (KTS) and Phakomatosis pigmentovascularis (PPV).We describe the ocular findings in a patient with coexisting PPV, SWS and KTS.


Subject(s)
Klippel-Trenaunay-Weber Syndrome , Neurocutaneous Syndromes , Port-Wine Stain , Sturge-Weber Syndrome , Humans , Neurocutaneous Syndromes/complications , Neurocutaneous Syndromes/diagnosis , Sturge-Weber Syndrome/complications , Sturge-Weber Syndrome/diagnosis , Klippel-Trenaunay-Weber Syndrome/complications , Port-Wine Stain/complications
18.
BMJ Case Rep ; 15(8)2022 Aug 12.
Article in English | MEDLINE | ID: mdl-35961685

ABSTRACT

Pre-macular haemorrhage (PMH) can cause profound visual loss. Some surgeons prefer neodymium-doped yttrium aluminium garnet (Nd:YAG) hyaloidotomy as the first line of treatment due to being an easy technique and having a high success rate. However, the use of high energy close to the fovea can lead to various macular complications. We present a case of a patient who presented with PMH secondary to anaemic retinopathy. He underwent Nd:YAG laser hyaloidotomy, but developed a full-thickness macular hole. He further underwent vitrectomy and a type 1 closure was achieved. However, the visual gain was poor due to the large hole size and the collateral thermal damage. The hole may not close spontaneously, thus requiring surgical intervention. The surgical outcome of these holes depends on the size of the hole and the collateral thermal damage caused during the laser procedure.


Subject(s)
Lasers, Solid-State , Retinal Perforations , Humans , Lasers, Solid-State/therapeutic use , Male , Retinal Hemorrhage/etiology , Retinal Hemorrhage/surgery , Retinal Perforations/etiology , Retinal Perforations/surgery , Visual Acuity , Vitrectomy/methods
SELECTION OF CITATIONS
SEARCH DETAIL
...